4006-776-356 出国就医服务电话

免费获得国外相关药品，最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model

Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model

Study Description
Brief Summary:
This study is a prospective, multi-center, randomized controlled clinical study. It developed an innovative Tai Chi Cardiac Rehabilitation Program (TCCRP) for patients with chronic coronary syndrome (CCS) and evaluated the efficacy, acceptability and safety of TCCRP on patients with CCS in order to explore the possible mechanism of its feasibility.

Condition or disease Intervention/treatment Phase
Coronary Heart Disease Chronic Coronary Syndrome Behavioral: Control Group ：conventional exercise rehabilitation programs (CERP) Behavioral: Experimental Group ：Tai Chi cardiac rehabilitation program (TCCRP) Not Applicable

Detailed Description:
This study is a prospective, multi-center, randomized controlled clinical trial of 100 participants with chronic coronary syndrome (CCS) that compares Tai Chi cardiac rehabilitation program (TCCRP) with conventional exercise rehabilitation programs (CERP), with an allocation ratio of 1:1. A total of 6 months study period, including 1 month in-hospital rehabilitation, 2 months home-based rehabilitation and 3 months follow-up. The main outcome indicators were measured at baseline, 1 month, 3 months and 6 months. The secondary outcome measures will be measured at baseline and at 3 months.
Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Clinical Efficacy and Mechanism of Tai Chi Cardiac Rehabilitation Program（TCCRP） in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model: a Randomized Controlled Trial
Actual Study Start Date : October 17, 2019
Estimated Primary Completion Date : July 30, 2021
Estimated Study Completion Date : October 30, 2021
Arms and Interventions
Arm Intervention/treatment
Active Comparator: Control Group
Group received conventional exercise rehabilitation programs (CERP).
 Behavioral: Control Group ：conventional exercise rehabilitation programs (CERP)
The participants in the control group will receive a conventional exercise rehabilitation programs (CERP) thrice a week for 12 weeks. Each training session lasts for 60 minutes, including ordinary warm-up exercises (10 minutes), aerobic activity (30 minutes), resistive exercise (10 minutes), and cool-down exercises(10 minutes). Each training session includes:(1) an active warm-up including arm-swinging, gentle stretches of the neck, shoulders, spine, arms, legs and so on;(2) aerobic activity mainly including aerobic radio exercise;(3) resistive exercise mainly including elastic belt exercise;(4) cool-down session involving active and static stretching exercises with primary body movements.
Experimental: Experimental Group
Group received Tai Chi cardiac rehabilitation program(TCCRP).
 Behavioral: Experimental Group ：Tai Chi cardiac rehabilitation program (TCCRP)
Participants perform Tai Chi cardiac rehabilitation program(TCCRP) thrice a week for 12 weeks. Each training session lasts for 60 minutes, including Tai Chi warm-up exercises(10 minutes), Bafa Wubu of Tai Chi(30 minutes), Tai-Chi in conjunction with X-light-band resistance exercise(10 minutes), and Tai Chi cool-down exercises(10 minutes). All participants are encouraged to practice Tai Chi followed the instructional video until finishing 12-week exercise.
Outcome Measures
Primary Outcome Measures :
  1. Change in score of Chinese Perceived Stress Scale (CPSS) [ Time Frame: baseline, 1 month, 3 months, 6 months ]
    Chinese Perceived Stress Scale is a self-rated questionnaire, which assesses perceived stress. Chinese Perceived Stress Scale is consisted of 14 items, which are divided into two dimensions: sense of tension and loss of control. Higher scores indicate higher levels of stress，lower scores indicate lower levels of stress. Chinese Perceived Stress Scale will be evaluated at baseline, 1 month, 3 months and 6 months.

  2. Change in score of Medical Outcomes Study Questionnaire Short Form 36 Health Survey (36-Item Short Form Survey) [ Time Frame: baseline,1 month, 3 months, 6 months ]
    SF-36 Health Survey(SF-36) . This is a multi-purpose, short-form health survey with only 36 questions. SF-36 items cover eight domains: physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems and mental health. Higher scores indicate higher levels of health. SF-36 will be evaluated at baseline, 1 month, 3 months and 6 months.

  3. 6-minute walk test (6 MWT) [ Time Frame: baseline, 1 month, 3 months, 6months ]
    6-minute walk test (6 MWT). 6MWT measures the distance a patient can walk quickly on a flat, hard ground in 6 minutes. 6MWT will be evaluated at baseline, 1 month, 3 months and 6 months.


Secondary Outcome Measures :
  1. Body fat rate [ Time Frame: baseline, 3 months ]
    Body fat rate will be tested by the Inbody770 at baseline and 3 months (at the end of the intervention) through bioelectrical impedance analysis.

  2. Peak oxygen uptake（VO2Peak） [ Time Frame: baseline, 3 months ]
    Cardiopulmonary exercise test (CPET) is an objective method being increasingly used in a wide spectrum of clinical practice for assessing the functional capacity of patient with coronary heart disease. Peak oxygen uptake（VO2Peak）will be tested by CPET at baseline and 3 months (at the end of the intervention).

  3. Locomotor skills [ Time Frame: baseline，3 months ]
    Locomotor skills includes handgrip strength, balance and flexibility. Handgrip strength, which is used to determine the maximum isometric strength of the hand and forearm muscles, will be measured using the handgrip strength dynamometer produced by CAMRY (product type EH101). The best result from repeated tests of each hand will be recorded. The balance test mainly includes standing on one foot with eyes closed, standing on one foot with eyes open, standing in situ with closed eyes and so on. Flexibility will be measured by seated forward flexion test. Locomotor skills will be evaluated at baseline and at the end of the 3-month intervention.

  4. Left ventricular ejection fraction(LVEF) [ Time Frame: baseline, 3 months ]
    LVED Vi and LVEF are also to be assessed using echocardiography at baseline and at the end of the 12-week intervention.

  5. Heart rate variability [ Time Frame: baseline, 3 months ]
    Heart rate variability will be assessed at baseline and at the end of the 3-month intervention.

  6. Low-density lipoprotein [ Time Frame: baseline, 3 months ]
    Low-density lipoprotein inspections will be tested at baseline and at the end of the 3-month intervention using an automatic biochemical analyzer.

  7. Testing of intestinal flora [ Time Frame: baseline, 3 months ]
    Intestinal flora tests will be evaluated at baseline and at the end of the 3-month intervention.


Other Outcome Measures:
  1. Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: baseline, 3 months ]
    Generalized Anxiety Disorder-7 (GAD-7) is a 7-item self-report measure. The GAD-7 asks how often participants have been bothered by anxiety symptoms in the past 2 weeks. Items are rated on a 4-point Likert scale indicating symptom frequency, ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating GAD. According to the original authors, the total score can then be interpreted as indicating no/minimal anxiety (0-4), mild (5-9), moderate (10-14), or severe (15-21), with a reasonable cut-off value for identifying cases of GAD at 10 points. GAD-7 will be evaluated at baseline and at the end of the 3-month intervention.

  2. Patient Health Questionnaire-9 (PHQ-9) [ Time Frame: baseline, 3 months ]
    The Patient Health Questionnaire-9 (PHQ-9) is designed for use with adults in assessing and monitoring depression severity based on Diagnostic and Statistical Manual of Mental Disorders (4th ed.;DSM-IV); The PHQ-9 asks clients to check off the number of days they have been bothered by each of the PHQ-9 symptoms over the"last two weeks." The nine items, based on DSM criteria for diagnosis of depression, are used to generate scores of 0, 1, 2, or 3 to the response categories of "not at all," "several days," "more than half the days," and "nearly every day,". The higher the score, the more serious the depression. PHQ-9 will be evaluated at baseline and at the end of the 3-month intervention.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria

  1. Male or non-pregnant women aged from 18 to 80 years;
  2. Patients who met the stable angina pectoris in accordance with coronary heart disease;
  3. NYHA class Ι, Π or Ш;
  4. Participants were able to understand the purpose of clinical trials and voluntarily participate and sign informed consent.

Exclusion criteria

  1. Acute myocardial infarction (AMI) within 2 weeks;
  2. Severe aortic stenosis;
  3. Hypertrophic cardiomyopathy;
  4. Severe valvular heart disease;
  5. Malignant tachyarrhythmia;
  6. The patient compliance was poor and the clinical trial could not be completed according to the requirements.
  7. Combined exercise can cause deterioration of the nervous system, motor system disease, or rheumatic disease.
  8. In the past 3 months, those who regularly practice Tai Chi;
  9. Patients with gastrointestinal diseases, infectious diseases, renal insufficiency, and a history of gastrointestinal surgery within one year
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Ma Jing, doctor 13681257396 crystalma@126.com

Locations
Layout table for location information
China
Beijing Water Conservancy Hospital Recruiting
Beijing, China, 100036
Contact: Lianshan Zhao         
Chinese PLA General Hospital Recruiting
Beijing, China, 100853
Contact: Jing Ma         
Beijing Chaoyang District Anzhen Community Health Service Center Recruiting
Beijing, China
Contact: Hua Li         
Sponsors and Collaborators
Chinese PLA General Hospital
Beijing Normal University
Investigators
Layout table for investigator information
Principal Investigator: Jing Ma, doctor Department of Cardiology in Chinese PLA General Hospital
Tracking Information
First Submitted Date  ICMJE May 1, 2019
First Posted Date  ICMJE May 3, 2019
Last Update Posted Date December 9, 2020
Actual Study Start Date  ICMJE October 17, 2019
Estimated Primary Completion Date July 30, 2021   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: December 7, 2020)
  • Change in score of Chinese Perceived Stress Scale (CPSS) [ Time Frame: baseline, 1 month, 3 months, 6 months ]
    Chinese Perceived Stress Scale is a self-rated questionnaire, which assesses perceived stress. Chinese Perceived Stress Scale is consisted of 14 items, which are divided into two dimensions: sense of tension and loss of control. Higher scores indicate higher levels of stress，lower scores indicate lower levels of stress. Chinese Perceived Stress Scale will be evaluated at baseline, 1 month, 3 months and 6 months.
  • Change in score of Medical Outcomes Study Questionnaire Short Form 36 Health Survey (36-Item Short Form Survey) [ Time Frame: baseline,1 month, 3 months, 6 months ]
    SF-36 Health Survey(SF-36) . This is a multi-purpose, short-form health survey with only 36 questions. SF-36 items cover eight domains: physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems and mental health. Higher scores indicate higher levels of health. SF-36 will be evaluated at baseline, 1 month, 3 months and 6 months.
  • 6-minute walk test (6 MWT) [ Time Frame: baseline, 1 month, 3 months, 6months ]
    6-minute walk test (6 MWT). 6MWT measures the distance a patient can walk quickly on a flat, hard ground in 6 minutes. 6MWT will be evaluated at baseline, 1 month, 3 months and 6 months.
Original Primary Outcome Measures  ICMJE
 (submitted: May 1, 2019)
  • Change in peak oxygen consumption (VO2) [ Time Frame: baseline，3 months ]
    Cardio-pulmonary exercise experiment.Change from baseline peakVO2 at 3 months
  • Change in score of Medical Outcomes Study Questionnaire Short Form 36 Health Survey (36-Item Short Form Survey) [ Time Frame: baseline，3，6 months ]
    Change in score from baseline 36-Item Short Form Survey at 3 and 6 months . The 36-Item Short Form Survey has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100 Lower scores = more disability, higher scores = less disability, The sections consists of Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning, and Mental health.
  • Change in heart function capacity [ Time Frame: baseline，1，3 months ]
    Change from baseline in heart function capacity at 1 and 3 months .Ejection Fractions（EF，normal range 50-70% ，reflecting the ejection function of the ventricle）and Left ventricular diameter（LV,normal range35-50mm，reflecting heart function capacity ).
  • Change in cardiac New York Heart Association (NYHA) grade. [ Time Frame: baseline，3，6 months ]
    Change from baseline cardiac New York Heart Association (NYHA) grade at 3 and 6 months
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: December 7, 2020)
  • Body fat rate [ Time Frame: baseline, 3 months ]
    Body fat rate will be tested by the Inbody770 at baseline and 3 months (at the end of the intervention) through bioelectrical impedance analysis.
  • Peak oxygen uptake（VO2Peak） [ Time Frame: baseline, 3 months ]
    Cardiopulmonary exercise test (CPET) is an objective method being increasingly used in a wide spectrum of clinical practice for assessing the functional capacity of patient with coronary heart disease. Peak oxygen uptake（VO2Peak）will be tested by CPET at baseline and 3 months (at the end of the intervention).
  • Locomotor skills [ Time Frame: baseline，3 months ]
    Locomotor skills includes handgrip strength, balance and flexibility. Handgrip strength, which is used to determine the maximum isometric strength of the hand and forearm muscles, will be measured using the handgrip strength dynamometer produced by CAMRY (product type EH101). The best result from repeated tests of each hand will be recorded. The balance test mainly includes standing on one foot with eyes closed, standing on one foot with eyes open, standing in situ with closed eyes and so on. Flexibility will be measured by seated forward flexion test. Locomotor skills will be evaluated at baseline and at the end of the 3-month intervention.
  • Left ventricular ejection fraction(LVEF) [ Time Frame: baseline, 3 months ]
    LVED Vi and LVEF are also to be assessed using echocardiography at baseline and at the end of the 12-week intervention.
  • Heart rate variability [ Time Frame: baseline, 3 months ]
    Heart rate variability will be assessed at baseline and at the end of the 3-month intervention.
  • Low-density lipoprotein [ Time Frame: baseline, 3 months ]
    Low-density lipoprotein inspections will be tested at baseline and at the end of the 3-month intervention using an automatic biochemical analyzer.
  • Testing of intestinal flora [ Time Frame: baseline, 3 months ]
    Intestinal flora tests will be evaluated at baseline and at the end of the 3-month intervention.
Original Secondary Outcome Measures  ICMJE
 (submitted: May 1, 2019)
  • Change in exercise capacity [ Time Frame: baseline,1，3 months ]
    Change from baseline 6 minute walking distance at 1and 3 months.
  • Change in heart rate variability(HRV) [ Time Frame: baseline, 3 months ]
    Change from baseline heart rate variability (HRV) at 3months. Heart rate variability（HRV，evaluating of autonomic nerve functionThe SDNN,SDANN,RMSSD values of 24 hour time domain analysis were (141 ±39) ms, (127 ±35) ms and (27 ±l 2) ms;, respectively.The power spectrum, TP, LF and HF recorded in the static supine position for 5 minutes were (3 466 and 1 018) ms2, (1 170-416) ms2 and (975-203) ms2: LFnormal, HFnormal, and LF/ HF were (54-24) nu, (29-3) nu, and 1.5-2.0, respectively).
  • Change in inflammatory factor level [ Time Frame: baseline，3 months ]
    Change from baseline inflammatory factor level at 3 months. Inflammatory factor（TNF-α，normal 1.14±0.04g/L ；IL-6，normal 108.85±41.48ng/L，hs-CRP，normal<10mg/L).
Current Other Pre-specified Outcome Measures
 (submitted: December 7, 2020)
  • Generalized Anxiety Disorder-7 (GAD-7) [ Time Frame: baseline, 3 months ]
    Generalized Anxiety Disorder-7 (GAD-7) is a 7-item self-report measure. The GAD-7 asks how often participants have been bothered by anxiety symptoms in the past 2 weeks. Items are rated on a 4-point Likert scale indicating symptom frequency, ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating GAD. According to the original authors, the total score can then be interpreted as indicating no/minimal anxiety (0-4), mild (5-9), moderate (10-14), or severe (15-21), with a reasonable cut-off value for identifying cases of GAD at 10 points. GAD-7 will be evaluated at baseline and at the end of the 3-month intervention.
  • Patient Health Questionnaire-9 (PHQ-9) [ Time Frame: baseline, 3 months ]
    The Patient Health Questionnaire-9 (PHQ-9) is designed for use with adults in assessing and monitoring depression severity based on Diagnostic and Statistical Manual of Mental Disorders (4th ed.;DSM-IV); The PHQ-9 asks clients to check off the number of days they have been bothered by each of the PHQ-9 symptoms over the"last two weeks." The nine items, based on DSM criteria for diagnosis of depression, are used to generate scores of 0, 1, 2, or 3 to the response categories of "not at all," "several days," "more than half the days," and "nearly every day,". The higher the score, the more serious the depression. PHQ-9 will be evaluated at baseline and at the end of the 3-month intervention.
Original Other Pre-specified Outcome Measures
 (submitted: May 1, 2019)
  • Change in oxidation resistance [ Time Frame: baseline, 3 months ]
    Change from baseline oxidation resistance at 3 months. Oxidation resistance（SOD，normal Enzyme rate method (37 ℃) serum 242 μ g / g ·Hb, erythrocytes 5375 ~ 7975 μ g / g ·mol / L and RBC 5375 ~ 7975 μ g / g ·mol ~ (- 1); GSP-Px，normal Enzyme rate method (37 ℃): 2.96~83U/ g ·Hb）.
  • Change in score of seattle angina scale. [ Time Frame: baseline，3，6 months ]
    Change from baseline seattle angina scale at 3 and 6 months. Seattle angina score（The Seattle Angina Scale (SAQ) was used to determine the total number of 9 problems,and the five dimensions of the disease，including the degree of physical activity, the steady state of angina, the frequency of angina, the degree of satisfaction of the treatment.).The higher the score, the better the quality of life and body function.
  • Change in score of Montreal Cognitive Assessment (MoCA) [ Time Frame: baseline，3，6 months ]
    Change from baseline Montreal Cognitive Assessment (MoCA) at 3 and 6 months.
  • incidence of rehospitalization [ Time Frame: baseline，3，6 months ]
    incidence of rehospitalization
 
Descriptive Information
Brief Title  ICMJE Efficacy and Mechanism of TCCRP in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model
Official Title  ICMJE Clinical Efficacy and Mechanism of Tai Chi Cardiac Rehabilitation Program（TCCRP） in Patients With Chronic Coronary Syndrome Under Fusion Cardiac Rehabilitation Model: a Randomized Controlled Trial
Brief Summary This study is a prospective, multi-center, randomized controlled clinical study. It developed an innovative Tai Chi Cardiac Rehabilitation Program (TCCRP) for patients with chronic coronary syndrome (CCS) and evaluated the efficacy, acceptability and safety of TCCRP on patients with CCS in order to explore the possible mechanism of its feasibility.
Detailed Description This study is a prospective, multi-center, randomized controlled clinical trial of 100 participants with chronic coronary syndrome (CCS) that compares Tai Chi cardiac rehabilitation program (TCCRP) with conventional exercise rehabilitation programs (CERP), with an allocation ratio of 1:1. A total of 6 months study period, including 1 month in-hospital rehabilitation, 2 months home-based rehabilitation and 3 months follow-up. The main outcome indicators were measured at baseline, 1 month, 3 months and 6 months. The secondary outcome measures will be measured at baseline and at 3 months.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Condition  ICMJE
  • Coronary Heart Disease
  • Chronic Coronary Syndrome
Intervention  ICMJE
  • Behavioral: Control Group ：conventional exercise rehabilitation programs (CERP)
    The participants in the control group will receive a conventional exercise rehabilitation programs (CERP) thrice a week for 12 weeks. Each training session lasts for 60 minutes, including ordinary warm-up exercises (10 minutes), aerobic activity (30 minutes), resistive exercise (10 minutes), and cool-down exercises(10 minutes). Each training session includes:(1) an active warm-up including arm-swinging, gentle stretches of the neck, shoulders, spine, arms, legs and so on;(2) aerobic activity mainly including aerobic radio exercise;(3) resistive exercise mainly including elastic belt exercise;(4) cool-down session involving active and static stretching exercises with primary body movements.
  • Behavioral: Experimental Group ：Tai Chi cardiac rehabilitation program (TCCRP)
    Participants perform Tai Chi cardiac rehabilitation program(TCCRP) thrice a week for 12 weeks. Each training session lasts for 60 minutes, including Tai Chi warm-up exercises(10 minutes), Bafa Wubu of Tai Chi(30 minutes), Tai-Chi in conjunction with X-light-band resistance exercise(10 minutes), and Tai Chi cool-down exercises(10 minutes). All participants are encouraged to practice Tai Chi followed the instructional video until finishing 12-week exercise.
Study Arms  ICMJE
  • Active Comparator: Control Group
    Group received conventional exercise rehabilitation programs (CERP).
    Intervention: Behavioral: Control Group ：conventional exercise rehabilitation programs (CERP)
  • Experimental: Experimental Group
    Group received Tai Chi cardiac rehabilitation program(TCCRP).
    Intervention: Behavioral: Experimental Group ：Tai Chi cardiac rehabilitation program (TCCRP)
Publications *
  • Yang YL, Wang YH, Wang SR, Shi PS, Wang C. The Effect of Tai Chi on Cardiorespiratory Fitness for Coronary Disease Rehabilitation: A Systematic Review and Meta-Analysis. Front Physiol. 2018 Jan 4;8:1091. doi: 10.3389/fphys.2017.01091. eCollection 2017.
  • Pozzan R, Da Cruz P di M, Castier MB, Barbosa EC, Barbosa JS, Da Rocha PJ, Albanesi Filho FM, Ginefra P, Gomes Filho JB. [Cardiac rehabilitation of patients with coronary disease. Evaluation after 3 and 6 months of aerobic training at the community level]. Arq Bras Cardiol. 1988 May;50(5):305-10. Portuguese.
  • Ferguson RJ, Bourassa MG, Côté P, Chaitman BR. [Cardiovascular effects of exercise and physical training in coronary disease]. Union Med Can. 1979 Oct;108(10):1187-94. Review. French.
  • Fernandes F, Morais C, Esteves M, Camilo V, Nazaré J, da Cunha JC, Amram SS. [Atrial pacing and the exercise test in the evaluation of coronary disease. A comparative study]. Rev Port Cardiol. 1990 Sep;9(9):675-9. Portuguese.
  • Hartung GH. Diet and exercise in the regulation of plasma lipids and lipoproteins in patients at risk of coronary disease. Sports Med. 1984 Nov-Dec;1(6):413-8. Review.
  • Ferguson RJ, Petitclerc R, Choquette G, Chaniotis L, Gauthier P, Huot R, Allard C, Jankowski L, Campeau L. Effect of physical training on treadmill exercise capacity, collateral circulation and progression of coronary disease. Am J Cardiol. 1974 Dec;34(7):764-9.
  • Leprêtre PM, Ghannem M, Bulvestre M, Ahmaidi S, Delanaud S, Weissland T, Lopes P. Exercise-based Cardiac Rehabilitation in Coronary Disease: Training Impulse or Modalities? Int J Sports Med. 2016 Dec;37(14):1144-1149. Epub 2016 Nov 10.
  • Sharma S, Malhotra A. Exercise testing and coronary disease: pushing fitness to higher peaks. Eur Heart J. 2019 May 21;40(20):1640-1642. doi: 10.1093/eurheartj/ehy777.
  • Caruso FR, Junior JC, Mendes RG, Sperling MP, Arakelian VM, Bassi D, Arena R, Borghi-Silva A. Hemodynamic and metabolic response during dynamic and resistance exercise in different intensities: a cross-sectional study on implications of intensity on safety and symptoms in patients with coronary disease. Am J Cardiovasc Dis. 2016 May 18;6(2):36-45. eCollection 2016.
  • Chow CK, Redfern J, Thiagalingam A, Jan S, Whittaker R, Hackett M, Graves N, Mooney J, Hillis GS. Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol. BMJ Open. 2012 Jan 19;2(1):e000606. doi: 10.1136/bmjopen-2011-000606. Print 2012.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P. Microvascular coronary disease in women: role of the cardiopulmonary exercise testing. Int J Cardiol. 2013 Oct 3;168(3):3012-3. doi: 10.1016/j.ijcard.2013.04.055. Epub 2013 May 7.
  • Ma J, Zhang JW, Li H, Zhao LS, Guo AY, Chen ZH, Yuan W, Gao TM, Li YM, Li CH, Wang HW, Song B, Lu YL, Cui MZ, Wei QY, Lyu SJ, Yin HC. Safety and effectiveness of a Tai Chi-based cardiac rehabilitation programme for chronic coronary syndrom patients: study protocol for a randomised controlled trial. BMJ Open. 2020 Jul 5;10(7):e036061. doi: 10.1136/bmjopen-2019-036061.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: December 7, 2020) 		100
Original Estimated Enrollment  ICMJE
 (submitted: May 1, 2019) 		150
Estimated Study Completion Date  ICMJE October 30, 2021
Estimated Primary Completion Date July 30, 2021   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion criteria

  1. Male or non-pregnant women aged from 18 to 80 years;
  2. Patients who met the stable angina pectoris in accordance with coronary heart disease;
  3. NYHA class Ι, Π or Ш;
  4. Participants were able to understand the purpose of clinical trials and voluntarily participate and sign informed consent.

Exclusion criteria

  1. Acute myocardial infarction (AMI) within 2 weeks;
  2. Severe aortic stenosis;
  3. Hypertrophic cardiomyopathy;
  4. Severe valvular heart disease;
  5. Malignant tachyarrhythmia;
  6. The patient compliance was poor and the clinical trial could not be completed according to the requirements.
  7. Combined exercise can cause deterioration of the nervous system, motor system disease, or rheumatic disease.
  8. In the past 3 months, those who regularly practice Tai Chi;
  9. Patients with gastrointestinal diseases, infectious diseases, renal insufficiency, and a history of gastrointestinal surgery within one year
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 80 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Ma Jing, doctor 13681257396 crystalma@126.com
Listed Location Countries  ICMJE China
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03936504
Other Study ID Numbers  ICMJE S2019-060-03
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: Yes
Plan Description: 6 months after republication
Supporting Materials: Study Protocol
Supporting Materials: Statistical Analysis Plan (SAP)
Supporting Materials: Informed Consent Form (ICF)
Supporting Materials: Clinical Study Report (CSR)
Time Frame: starting 6 months after publication
Access Criteria: The IPD of the publication will be shared, including characteristic data,results, clinical follow up data.
Responsible Party Jing Ma, Chinese PLA General Hospital
Study Sponsor  ICMJE Chinese PLA General Hospital
Collaborators  ICMJE Beijing Normal University
Investigators  ICMJE
Principal Investigator: Jing Ma, doctor Department of Cardiology in Chinese PLA General Hospital
PRS Account Chinese PLA General Hospital
Verification Date December 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

治疗医院

新药特效药

前沿医讯